Lee E. Babiss, PhDCEO, Gotham Therapeutics Corp.; Co-Founder and President at SYNBLic Therapeutics Inc.
Dr. Lee Babiss has an illustrious career across academia, pharma, biotech, and CRO. He served as VP of human genetics and personalized health care at GlaxoWellcome, Global R & D head at Roche, and CSO of PPD, in addition to his most recent tenure as President and Board Chairman of X-Chem and CEO of X-Rx.
Dr. Babiss received his doctorate in Microbiology from Columbia University and completed his postdoctoral fellowship at the Rockefeller University, where he served as an assistant and associate professor. Dr. Babiss has published over 70 peer-reviewed scientific papers on Science and PNAS etc., and serves on numerous scientific advisory committees and boards including NIH Scientific Management Review Board, Board of Director at Moderna Therapeutics Inc., Scientific Advisory Board at Versant Ventures etc.